Texas HB975 allows patients with life-threatening or severely debilitating illnesses to access cutting-edge treatments.

HB975 amends the Texas Health and Safety Code to allow patients with life-threatening or severely debilitating illnesses to access individualized investigational treatments. Patients must provide written informed consent, which must be attested to by their physician and a witness. The bill defines "individualized investigational treatment" as a drug, biological product, or device unique to a patient based on their genetic profile. Health care facilities and manufacturers can provide these treatments without compensation or at the patient's expense.

Texas HB975 allows patients with life-threatening or severely debilitating illnesses to access cutting-edge treatments.

HB975 amends the Texas Health and Safety Code to allow patients with life-threatening or severely debilitating illnesses to access individualized investigational treatments. Patients must provide written informed consent, which must be attested to by their physician and a witness. The bill defines "individualized investigational treatment" as a drug, biological product, or device unique to a patient based on their genetic profile. Health care facilities and manufacturers can provide these treatments without compensation or at the patient's expense.